Trilogy Writing and Consulting Logo

Market Access and Reimbursement

April 23, 2015 | Frankfurt, Germany

Trilogy hosted a discussion during which we explored strategies for how to make sure that your Clinical Development Programme meets not only the needs for regulatory approval, but also the needs for market access and reimbursement, together with our speakers:

  • Dr. Boris Pfeiffer (Director Global Evidence & Value Development, Merck, and representative in the IMI GetReal project)
  • Dr. Thomas Wagner (Medical Writing Manager at Trilogy Writing & Consulting)